What is Allergy Options?
Established in 2012, Allergy Options is dedicated to enhancing the treatment of allergies, a condition affecting 40 million individuals nationally. The company focuses on providing more effective and accessible allergy testing and treatment options, particularly in regions like North Texas where allergy symptoms are on the rise. Allergy Options partners with primary care physicians, integrating allergy services directly into their practices. This co-location model ensures that patients benefit from convenient access to allergy care, grounded in a thorough medical history provided by their trusted doctor. This approach offers a significant improvement over traditional methods of merely managing symptoms with medication or enduring seasonal discomfort.
How much funding has Allergy Options raised?
Allergy Options has raised a total of $32K across 1 funding round:
Debt
$32K
Debt (2021): $32K with participation from PPP
What's next for Allergy Options?
With significant Series B/C stage backing, Allergy Options is poised for accelerated growth and market penetration. The recent influx of expansion capital is expected to fuel strategic initiatives, potentially including the scaling of its co-located service model to new geographic areas or enhancing its diagnostic and treatment technologies. The company's focus on a physician-integrated approach positions it to capture a larger share of the allergy treatment market by offering a more comprehensive and patient-centric solution.
See full Allergy Options company page
